The Discovery and Development of AZD1402/PRS-060, an Inhaled, Potent and Selective Antagonist of the IL-4 Receptor Alpha
G. Matschiner (Boston, United States of America), S. Huang (Geneva, Switzerland), S. Constant (Geneva, Switzerland), B. Rattenstetter (Boston, United States of America), H. Gille (Niederzier, Germany), A. Hohlbaum (Ghent, Belgium), B. Koller (Chapell Hill, United States of America), D. Keeling (Gothenburg, Sweden), M. Fitzgerald (Boston, United States of America)
Source: International Congress 2018 – Basic pharmacology
Session: Basic pharmacology
Session type: Thematic Poster
Number: 1047
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Matschiner (Boston, United States of America), S. Huang (Geneva, Switzerland), S. Constant (Geneva, Switzerland), B. Rattenstetter (Boston, United States of America), H. Gille (Niederzier, Germany), A. Hohlbaum (Ghent, Belgium), B. Koller (Chapell Hill, United States of America), D. Keeling (Gothenburg, Sweden), M. Fitzgerald (Boston, United States of America). The Discovery and Development of AZD1402/PRS-060, an Inhaled, Potent and Selective Antagonist of the IL-4 Receptor Alpha. 1047
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: